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Abstract 
Tinospora cordifolia extract decreased the activity of glycogen phosphorylase in the liver and widely used in the treatment of 
diabetes mellitus. This in silico study aimed to screen the active compound(s) of T. cordifolia which play a role in its 
hypoglycemic activity as glycogen phosphorylase inhibitor by molecular docking analysis. Thirteen chemical constituents of T. 
cordifolia were used as ligands for docking study. The glycogen phosphorylase structure was obtained from Brookhaven protein 
databank (1LWO). Docking analysis was performed using Autodock Vina and PyRx 8. The inhibitory activity was analyzed by 
comparison the binding energy and binding mode of interaction of T. cordifolia chemical constituents on glycogen 
phosphorylase. The results indicate that magnoflorine, cordiofolioside A, and syringin exhibited good affinity to glycogen 
phosphorylase, by interacted at catalytic site of enzyme 
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1. Introduction 
Malaria Liver is the major regulator of plasma glucose levels in the post absorptive state, and in type II diabetes 
hepatic glucose production is significantly elevated relative to nondiabetes. Glycogen phosphorylase, a key enzyme 
in the regulation of glycogen metabolism, catalyzes the degradative phosphorolysis of glycogen to glucose 1-
phosphate. Glycogen phosphorylase has been exploited as a specific target of inhibitors that might prevent 
glycogenolysis under high glucose level conditions in type II diabetes1,2. 
Some anti-diabetes drugs have one or more adverse effects, so the management of diabetes mellitus is still a 
challenge in the medical field. Recently, the search for appropriate antihyperglycemic agents has been focused on 
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traditional medicine product due to the lower side effect3. Tinospora cordifolia extract was reported can decrease the 
activity of glycogen phosphorylase in the liver and widely used in the treatment of diabetes mellitus4,5. A variety of 
chemical constituents have been isolated from T. cordifolia plant and their structures were elucidated. They belong 
to different classes such as alkaloids, diterpenoid lactones, glycosides, steroids, sesquiterpenoid, phenolics, aliphatic 
compounds and polysaccharides6,7.  
This in silico study aimed to screen the active compound(s) of T. cordifolia (figure 1), i.e. magnoflorine, 
cordiofolioside A, ecdysterone, syringin, palmatine, cordioside, tinocrisposide, berberine, tinocordiside, tembetarine, 
tinocordifolin, palmatoside as well as columbin, which play a role in its hypoglycemic activity as glycogen 
phosphorylase inhibitor by molecular docking using AutoDock Vina software. By molecular docking, the bound 
conformations and the binding affinity between chemical constituent of T. cordifolia and glycogen phosphorylase as 
target, could be predicted. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structures of T. cordifolia constituents. 
2. Experiments 
2.1. Trizol Ligands Preparation 
The thirteen structures of chemical constituents of T. cordifolia i.e. magnoflorine, cordiofolioside A, ecdysterone, 
syringin, palmatine, cordioside, tinocrisposide, berberine, tinocordiside, tembetarine, tinocordifolin, palmatoside as 
well as columbin (figure 1) were collected from published literatures6,7. The two-dimensional (2D) chemical 
structures of the ligands were sketched using ChemDraw Ultra 2008, and the energy minimizations of the prepared 
ligands were carried out with Chem3D Ultra and were saved in pdb format. 
2.2. Target Preparation and Validation of Docking Method 
The three dimensional structure of glycogen phosphorylase was obtained from Brookhaven protein databank 
(PDB ID: 1LWO). The  docking study was started with the definition of a binding site, in general a restricted region 
of the protein. The size and location of this binding site was visualized in PyMOL. The protein target were further 
validated with AutoDock Vina in PyRx 0.8 by RMSD value determination8.  
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2.3. Molecular Docking Analysis 
Binding mode and interaction of glycogen phosphorylase with individual chemical constituent of T. cordifolia, 
was performed using AutoDock Vina software. Docking was performed to obtain a population of possible 
conformations and orientations for the ligand at the binding site. The protein was loaded in PyRx software, creating 
a PDBQT file that contains a protein structure with hydrogens in all polar residues. All bonds of ligands were set to 
be rotatable. All calculations for protein-fixed ligand-flexible docking were done using the Lamarckian Genetic 
Algorithm (LGA) method. The docking site on protein target was defined by establishing a grid box with the 
dimensions of X: 38.0729 Y: 33.3208 Z: 25.0000 Å, with a grid spacing of 0.375 Å, centered on X: 20.2892 Y: 
10.3219 Z: 32.3218 Å. The best conformation was chosen with the lowest docked energy, after the docking search 
was completed. Ten runs with AutoDock Vina were performed in all cases per each ligand structure, and for each 
run the best pose was saved. The average affinity for best poses was taken as the final affinity value. The interactions 
of complex glycogen phosphorylase protein-ligand conformations, including hydrogen bonds and the bond lengths 
were analyzed using PyMol. 
3. Results and Discussion 
Docking of small molecule compounds into the binding site of a receptor and estimating the binding affinity of 
the complex is an important part of the structure based drug design process. AutoDock Vina is a open-source 
program for drug discovery, molecular docking and virtual screening, offering multicore capability, high 
performance and enhanced accuracy and ease tof use.  The parameters chosen for the docking can be judged by the 
docking tool’s ability to reproduce the binding mode of a ligand to protein, when the structure of the ligand–protein 
complex is known. The criterion usually used is the all atom root mean square deviation (RMSD) between the 
docked position and the crystallographically observed binding position of the ligand, and success is typically 
regarded as being less than 2Å9. 
In this study, the native ligand was CP320626 (5-chloro-1H-indole-2-carboxylic acid [1-(4-fluorbenzyl)-2-(4-
hydroxypiperidin-1yl)-2-oxoethyl] amide). This compound has been identified as a potent inhibitor of human liver 
glycogen phosphorylase. CP320626 is also a potent inhibitor of human muscle glycogen phosphorylase. 
Oikonomakos et al. elucidated the structural basis of the inhibition mechanism of CP320626, by determination the 
complex of rabbit muscle glycogen phosphorylase with CP3206261. Figure 2 showed the model of interaction 
between CP320626 and binding site of glycogen phosphorylase. Amino acids residues of glycogen phosphorylase 
which involved in interaction with CP320626 were Glu190A, Arg60A and Lys191A. A hydrogen bond was occured 
between carbonyl group of Glu190A as hydrogen bond acceptor and –NH of indole ring as hydrogen bond donor. 
Between cationic center of Arg60A and anionic center of CP320626, an electrostatic interaction was formed. 
Prathipati et al. reported that the mayor interaction between CP320626 and the enzyme are hydrophobic interactions 
between the indole-aromatic ring and hydrophobic residues such as Pro229, Trp189, and Trp67 which is represented 
by a hydrophobic feature on the indole-ring1. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Model of interaction of CP320626 and glycogen phosphorylase binding site 
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Figure 3 showed the superimposition of CP320626 from the X-ray crystal structure and from the docking result. 
The RMSD value was 1.765 Å, indicated that Autodock-Vina's algorithms used in this research were valid. In 
addition, both of ligands (native ligand and that from the docking simulation) interacted to the same amino acid 
residues of glycogen phosphorylase, i.e. Arg60A and Glu190A, so this docking method then was used to perform 
the docking calculation of the chemical constituents of T. cordifolia 
 
 
 
 
 
Figure 3. Superimposition of CP320626 from The X-Ray Crystal Structure (atom C in blue) and from the Docking Result (atom C in cyan) 
Structures of selected chemical constituents of T. cordifolia were used as ligands for molecular docking to 
glycogen phosphorylase binding site, and the binding affinity was characterized by binding energy (ΔG) value. 
Among 13 chemical constituents of  T. cordifolia, magnoflorin, cordiofolioside A and syringin showed the best 
binding energy (ΔG) value, i.e. -8.80, -8.830,  and -8.20 kcal/mole, respectively (table 1).  
  
Table 1. Binding Energy of T. cordifolia Chemical Constituents 
Ligands Binding Energy (kcal/mole) 
magnoflorine -8.80 ± 0.95 
cordiofolioside-A -8.30 ± 0.87 
syringin -8.20 ± 0.91 
palmatine -7.90 ± 0.76 
cordioside -7.30 ± 0.84 
tinocrisposide -7.10 ± 0.66 
columbin  -7.00 ± 0. 76 
tinocordiside -7.00 ± 0.98 
ecdysterone -6.90 ± 0.79 
palmatoside -6.70 ± 0.80 
tembetarine -6.70 ± 0.54 
tinocordifolin -6.10 ± 0.92 
berberine -3.00 ± 0,71 
 
Glycogen phosphorylase has at least six different ligand binding sites, i.e. (1) the Ser14-phosphate recognition 
site, (2) the catalytic site that binds glycogen, glucose-1-P, glucose and glucose analogues, (3) the AMP allosteric 
site, (4) the purine nucleoside site, (5) the glycogen storage site, and (6) the dimer interface site, which binds indole 
derivatives. The catalytic site, the AMP allosteric site, the inhibition site and the dimer interface site are known to be 
inhibitor binding sites10. The allosteric site is made up of helices α2 (residues 47-78), α8 (residues 289-314), β4 
(residues 153-160), β10 (residues 222-232), β11 (residues 237-247), β7 (residues 191-193) and the loop (residues 
195-197). Ligands occupying this site are able to inhibit this enzyme by either direct and/or indirect inhibition of 
AMP binding. CP320626 acted as inhibitor by interacted to to the new allosteric (or indole) site, located inside the 
central cavity of the dimeric enzyme of the enzyme11.  
Location of interaction site of the ligands in the enzyme, which were different from the interaction site of 
CP320626. Magnoflorin, cordiofolioside A, syringin, palmatine, as well as tinocordiofoline interacted at the catalytic 
sites of the enzyme. Somsák et al. reported that the catalytic site is buried at the centre of the enzyme, consists of 
residues α6 (134-150), β13 (371-376), and β18 (478-484) in domain 1 and from β 19 (562-570), the loop (571-574) 
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between β 19 (562-570) and β 18 (575-593), and the loop (666-675) between β 22 (661-665) and β 21 (676-684) in 
domain 211. Other ligands did not locate at any potential regulatory sites. 
Magnoflorine, an isoquinoline alkaloid, as well as cordifolioside A and syringin (phenylpropanoid compounds), 
showed the lowest binding energy that indicated the highest affinity to the enzyme. Figure 5 showed the binding 
modes of these compounds in the catalytic site pocket of GP and the hydrogen bonds contributed for the binding. 
Catalytic site of GP binds glycogen and glucose-1-P as well as glucose and glucose analogues. Cordifolioside A and 
syringin are glycoside compounds; this enabled their interaction with catalytic site of GP. Large compounds with 
glucopyranosylamine structure have synthesized and showed the GP inhibition activity11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The binding mode of magnoflorine, syringin and  cordiofolioside A in the catalytic site pocket of GP. The hydrogen bonds between 
ligands and residues are indicated as broken lines 
4. Conclusion 
The results indicated that Autodock-Vina's algorithms were valid, as re-docking the native ligand to binding site 
of glycogen phosphorylase showed a RSMD value less than 2 A 1.765. The docking result revealed that 
magnoflorin, cordiofolioside A, and syringin exhibited good binding interaction to catalytic site of glycogen 
phosphorylase 
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